Related Experiment Video
Updated: Jul 20, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3
Harsh Patolia1, Muhammad Shahzeb Khan2, Gregg C Fonarow3
1Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Insights
Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) is underutilized, despite its proven benefits. This review explores implementation strategies to improve GDMT delivery and patient outcomes.
Area of Science:
- Cardiology
- Implementation Science
Background:
- Heart failure with reduced ejection fraction (HFrEF) remains a leading cause of mortality and hospitalization.
- Significant gaps exist in the utilization of guideline-directed medical therapy (GDMT) for eligible HFrEF patients.
- Despite available therapies, suboptimal care delivery persists, highlighting an urgent need for improved treatment strategies.
Purpose of the Study:
- To review and contextualize evidence for various implementation strategies aimed at improving GDMT utilization in HFrEF.
- To identify effective methods for bridging the gap between guideline recommendations and clinical practice for HFrEF management.
Main Methods:
- Comprehensive review of existing literature on implementation strategies for HFrEF GDMT.
- Analysis of evidence supporting various approaches, including in-hospital initiation, multidisciplinary clinics, and digital health interventions.
Main Results:
- Multiple evidence-based strategies can enhance GDMT delivery for HFrEF.
- Successful implementation requires tailored approaches, addressing barriers like cost, patient education, and system integration.
- Initiatives range from direct patient engagement to leveraging electronic health records and quality improvement programs.
Conclusions:
- Improving GDMT uptake in HFrEF is feasible through diverse implementation strategies.
- A multi-faceted approach combining clinical interventions, system-level changes, and patient-centered education is crucial.
- Optimizing GDMT delivery can significantly reduce HFrEF-related morbidity and mortality.
Abstract:
Despite the availability of lifesaving guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF), there remain major gaps in utilization of these therapies among eligible patients. Simultaneous with these gaps in quality of care, HFrEF continues as a leading cause of death and hospitalization with associated clinical risk far exceeding most other cardiovascular and noncardiovascular conditions. In the context of this urgent need to improve provision of appropriate therapy, multiple lines of evidence support various implementation strategies. Such strategies include in-hospital initiation of GDMT, simultaneous or rapid sequence initiation of GDMT, participation in quality improvement registries to assess site performance and provide feedback, multidisciplinary titration clinics, virtual consult teams, reduction of cost-sharing, remote algorithm-based medication optimization, electronic health record-based interventions, and direct-to-patient educational initiatives. This review describes and contextualizes the evidence surrounding each of these potential avenues for improving use of foundational GDMTs for patients with HFrEF.
More Related Videos
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Rheumatic Heart Disease III: Medical Management
Heart Failure VII: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System